These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29053894)

  • 1. French translation and cross-cultural adaptation of The Myotonic Dystrophy Health Index.
    Gagnon C; Tremblay M; CôTé I; Heatwole C
    Muscle Nerve; 2018 Apr; 57(4):686-689. PubMed ID: 29053894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myotonic dystrophy health index: Japanese adaption and validity testing.
    Mori I; Fujino H; Matsumura T; Takada H; Ogata K; Nakamori M; Innami K; Shingaki H; Imura O; Takahashi MP; Heatwole C
    Muscle Nerve; 2019 May; 59(5):577-582. PubMed ID: 30681157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.
    Sansone VA; Lizio A; Greco L; Gragnano G; Zanolini A; Gualandris M; Iatomasi M; Heatwole C
    Neuromuscul Disord; 2017 Nov; 27(11):1047-1053. PubMed ID: 28890289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic Dystrophy Health Index: initial evaluation of a disease-specific outcome measure.
    Heatwole C; Bode R; Johnson N; Dekdebrun J; Dilek N; Heatwole M; Hilbert JE; Luebbe E; Martens W; Mcdermott MP; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley R
    Muscle Nerve; 2014 Jun; 49(6):906-14. PubMed ID: 24142420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
    Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
    Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
    Symonds T; Randall JA; Campbell P
    Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. French translation and linguistic validation of a new Patient Reported Outcome instrument: the BODY-Q: A description of the process.
    Rillon P; Château F; Klassen A; Tsangaris E; Geneviève P; De Coninck C
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):406-410. PubMed ID: 31488761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy patient preferences in patient-reported outcome measures.
    Heatwole C; Johnson N; Dekdebrun J; Dilek N; Eichinger K; Hilbert J; Luebbe E; Martens W; Mcdermott MP; Thornton C; Moxley R
    Muscle Nerve; 2018 Jan; ():. PubMed ID: 29328504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translation and cross-cultural adaptation of eight pediatric PROMIS® item banks into Spanish and German.
    Devine J; Schröder LA; Metzner F; Klasen F; Moon J; Herdman M; Hurtado MP; Castillo G; Haller AC; Correia H; Forrest CB; Ravens-Sieberer U
    Qual Life Res; 2018 Sep; 27(9):2415-2430. PubMed ID: 29766439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Completion of the French Translation and Linguistic Validation of the BODY-Q.
    Schettini AV; Rillon P; Pirson G; De Coninck C
    Psychiatr Danub; 2020 Sep; 32(Suppl 1):150-152. PubMed ID: 32890380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcome Evaluations and CBT Response Prediction in Myotonic Dystrophy.
    van As D; Okkersen K; Bassez G; Schoser B; Lochmüller H; Glennon JC; Knoop H; van Engelen BGM; 't Hoen PAC;
    J Neuromuscul Dis; 2021; 8(6):1031-1046. PubMed ID: 34250945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
    Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
    Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling the myotonic dystrophy type 1 clinical spectrum: A systematic registry-based study with implications for disease classification.
    De Antonio M; Dogan C; Hamroun D; Mati M; Zerrouki S; Eymard B; Katsahian S; Bassez G;
    Rev Neurol (Paris); 2016 Oct; 172(10):572-580. PubMed ID: 27665240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Living with Medicines Questionnaire: Translation and Cultural Adaptation into the Arabic Context.
    Zidan A; Awaisu A; Hasan S; Kheir N
    Value Health Reg Issues; 2016 Sep; 10():36-40. PubMed ID: 27881275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. French translation and cross-cultural adaptation of the Michigan Hand Outcomes Questionnaire and the Brief Michigan Hand Outcomes Questionnaire.
    Efanov JI; Shine JJ; Darwich R; Besner Morin C; Arsenault J; Harris PG; Danino AM; Izadpanah A
    Hand Surg Rehabil; 2018 Apr; 37(2):86-90. PubMed ID: 29373241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological characteristics of patients with myotonic dystrophy type 1.
    Bertrand JA; Jean S; Laberge L; Gagnon C; Mathieu J; Gagnon JF; Richer L
    Acta Neurol Scand; 2015 Jul; 132(1):49-58. PubMed ID: 25496310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.
    Baldanzi S; Bevilacqua F; Lorio R; Volpi L; Simoncini C; Petrucci A; Cosottini M; Massimetti G; Tognoni G; Ricci G; Angelini C; Siciliano G
    Orphanet J Rare Dis; 2016 Apr; 11():34. PubMed ID: 27044540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective measurement of quality of life in myotonic dystrophy type 1.
    Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
    Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation, cross-cultural adaptation, and validation of the french version of the 15-item Myasthenia Gravis Quality Of life scale.
    Birnbaum S; Ghout I; Demeret S; Bolgert F; Eymard B; Sharshar T; Portero P; Hogrel JY
    Muscle Nerve; 2017 May; 55(5):639-645. PubMed ID: 27533497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity, reliability and responsiveness of the French language translation of the Western Ontario Shoulder Instability Index (WOSI).
    Gaudelli C; Balg F; Godbout V; Pelet S; Djahangiri A; Griffin S; Rouleau DM
    Orthop Traumatol Surg Res; 2014 Feb; 100(1):99-103. PubMed ID: 24332720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.